STEPHANIE WIGGINS: Open Payments
NPI 1457721359 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,475 in 107 payments from 19 companies in 2025. Trend: 2023 $1,323 · 2024 $968 · 2025 $1,475
Food & beverage: $1,475
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $315 |
| PFIZER INC. | 24 | $281 |
| Amgen Inc. | 13 | $153 |
| Lilly USA, LLC | 10 | $124 |
| Astellas Pharma US Inc | 4 | $105 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Novo Nordisk Inc | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Lundbeck LLC | 2 | $44 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
Products named: NURTEC ODT, UBRELVY, REXULTI, Veozah, MOUNJARO, ELIQUIS, VRAYLAR, OTEZLA.
Industry payments across AR — which companies pay providers there.
